Polymers on drug-eluting stents (DES) assure the needed drug-release kinetics for the efficacy of DES. However, polymer-induced impaired vascular healing is associated with late stent thrombosis and restenosis after DES implantation. In pharmacokinetic studies DES simultaneous coated with highly lipophilic probucol and sirolimus (Dual-DES) showed the same release kinetic as permanent-based DES. In the randomized ISAR-TEST-5 trial (n=3002) we demonstrated equal performance of Dual-DES and permanent-polymer zotarolimus-eluting stent regarding primary target lesion failure and stent thrombosis at 1 year follow-up.
«
Polymers on drug-eluting stents (DES) assure the needed drug-release kinetics for the efficacy of DES. However, polymer-induced impaired vascular healing is associated with late stent thrombosis and restenosis after DES implantation. In pharmacokinetic studies DES simultaneous coated with highly lipophilic probucol and sirolimus (Dual-DES) showed the same release kinetic as permanent-based DES. In the randomized ISAR-TEST-5 trial (n=3002) we demonstrated equal performance of Dual-DES and permane...
»